Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small
Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Does the drug nivolumab help treat patients with non-small cell lung cancer?
Basic Study Information
Purpose:Location: University of Rochester
This phase III ALCHEMIST trial studies how well nivolumab after surgery and chemotherapy
work in treating patients with stage IB-IIIA non-small cell lung cancer. Monoclonal
antibodies, such as nivolumab, may stimulate the immune system in different ways and
kill tumor cells remaining after surgery and standard of care chemotherapy.
Study Contact InformationPhone: (585) 275-5830
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search